Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of Joint Stockbroker

24th Aug 2009 15:58

24 August 2009 Source BioScience plc (`Source BioScience' or `the Company') Appointment of Joint Stockbroker

The Board of Source BioScience plc is pleased to announce the appointment, with immediate effect, of Daniel Stewart Securities as joint stockbroker, alongside Charles Stanley Securities the Company's existing joint stockbroker, sponsor, and financial advisor.

- ENDS -

For further information, please contact:

Source BioScience plcNick AshManaging DirectorTel: 0115 973 9010www.sourcebioscience.com

Daniel Stewart Securities (Joint Broker)

Martin LampshireTel: +44 207 776 6550www.danielstewart.co.ukAbout Source BioScience:

Source BioScience is a highly focused healthcare and biotechnology company providing diagnostic and screening services to the healthcare community and genetic analyses and biomolecular tools and products to the life science research and pharma biotech sectors.

Its Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases and additional predictive testing for treatment optimisation for clinicians and patients. Pharma Biotech Services offers support for early stage therapeutic development, offering a 'one-stop shop' from tissue pathology, immunohistochemistry, sophisticated image analysis, biomarker determination and assay development to pharmacogenomics including genotyping and gene expression analysis. Life Science Research services provide core laboratory research support from conceptualization to implementation, calling upon a wide range of cutting-edge technology platforms including an online catalogue of biomolecular tools. This incorporates DNA sequencing, whole genome amplification and a comprehensive library of genomic reagents and clones including cDNA and RNAi, as well as facilitating rapid access to high quality antibodies, cell cultures, diagnostic assays for cancer and other genetic testing, and related research tools.

The Group has its headquarters in Nottingham, UK where it operates state of the art reference laboratory facilities, with additional UK laboratory facilities in London, Cambridge and Oxford. Source BioScience is CPA, GLP and GCP accredited and is licensed by the Human Tissue Authority.

Further information about Source BioScience can be found at www.sourcebioscience.com.

vendor

Related Shares:

SBS.L
FTSE 100 Latest
Value8,275.66
Change0.00